Ambient AI scribes arrived with a simple promise: give physicians their time back. On that narrow promise, they deliver. Clinicians type less. Voice feels natural. Notes appear in the EHR with less friction. Anyone who has finished charts at midnight knows that relief is real.
But after years of designing and deploying clinical technology inside real health systems, I have come to a less comfortable conclusion. AI documentation tools did not reduce clinician burden. They moved it.
They solve a real pain point very well. That does not mean they solve the right one.
From typing to vigilance
Clinical burden does not live in the act of documentation alone. It lives in the interfaces between systems, decisions and accountability.
Most AI scribes optimize a single interface: clinician to note. They smooth that interaction beautifully. The moment a note is generated, though, the real work begins. The clinician must verify accuracy, make sure intent survived, confirm the note supports billing and quality measures, and anticipate how payers, auditors and colleagues will read it later.
The interface has shifted from typing to vigilance. The burden has not disappeared. It has moved upstream, into cognitive oversight.
Tight integration with the dominant EHR platforms is often sold as a competitive moat. Integration can also mean tight coupling to the very constraints that create burden. If a tool is still designed to feed the EHR rather than relieve the work the EHR creates, speed alone changes little. It just moves clinicians through the same maze faster.
The interfaces no one touched
The underperformance shows up quietly, in the interfaces that remain untouched:
- Conflicting data sources that clinicians must reconcile by hand
- New information competing for limited attention
- Documentation that still has to become downstream coordination
- Risk signals that still depend on a person to turn them into action
This is where clinicians spend their mental energy. It is also where most documentation tools leave things exactly as they found them.
We are measuring the wrong thing
There is a reason nearly every ROI story is framed around minutes saved documenting. It is a clean metric, and easy to demonstrate.
The harder questions get asked less often. Are clinicians charting less after hours? Is the inbox lighter? Has decision fatigue dropped? Is cognitive load easier to carry in complex cases?
When those numbers do not move, enthusiasm cools quietly. Health systems renew with less conviction, and clinicians go back to feeling that technology is something done to them rather than for them.
Build for the work that should never exist
None of this means documentation tools lack value. They solve a visible pain point well. But solving a visible pain point is not the same as solving the right one.
Real burden reduction means intervening earlier in the clinical workflow: before the work is created, before ambiguity compounds, and before clinicians become the integration layer for fragmented systems.
The difference is easy to see when AI moves upstream. In clinical trial eligibility screening, for example, placing AI at the step where research staff once combed through charts by hand does not make the old process faster. It removes most of that process altogether. That is the standard every clinical AI tool should be held to.
That kind of progress needs more than better documentation interfaces. It needs tools shaped by clinicians themselves, focused on decision friction, prioritization and risk, not just speed.
The next generation of clinical AI will not be judged by how fast it writes notes. It will be judged by how much unnecessary work it prevents from existing at all.
That is a very different interface to design for. It is the one worth building.
Photo: Xavier Lorenzo, Getty Images
Dr. Ambreén Zaman Riaz, MD, MPA, is a physician and two-time founder who builds AI clinical decision support and precision health tools. She has led clinical AI strategy and deployment across more than 15 research sites and is a Harvard Kennedy School Edward S. Mason Fellow.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.
